Although further investigations are necessary to elucidate the detailed mechanisms of the CXCLs–CXCR2 axis dependency of PDAC progression, blocking CXCLs–CXCR2 axis in the crosstalk between tumor and stromal cells could be a promising therapeutic strategy for PDAC. The gene discussed is CXCR2; the disease is neoplasm.